Apogenix Receives FDA Orphan Drug Designation for Apocept(TM) to...

Apogenix / Apogenix Receives FDA Orphan Drug Designation for Apocept to Treat Myelodysplastic Syndromes and Initiates Clinical Phase I Study .

http://www.pr-inside.com/apogenix-receives-fda-orphan-drug-designation-for--r3578241.htm